02 Jun Iluvien Treats Diabetic Macular Edema for 3 Years
There's a new LONG TERM treatment for patients with diabetic macular edema. Iluvien is now available in the United States. It releases steroid and can improve your macular edema for years!...
There's a new LONG TERM treatment for patients with diabetic macular edema. Iluvien is now available in the United States. It releases steroid and can improve your macular edema for years!...
Iluvien receives further European approval for the treatment of diabetic macular edema. It has yet to be approved in the U.S. Iluvien is an injected sustained release system....
Iluvien, a sustained drug delivery system for the treatment of diabetic macular edema, gets closer to medical use in Europe. This novel treatment for DME remains viable....
Alimera Sciences suffers set back with Iluvien. In a complete response letter to the company, the FDA did not approve the device for diabetic retinopathy citing concerns over safety....
Iluvien, a sustained release intraocular drug delivery system, may get closer to FDA approval. The parent company just submitted additional safety/efficacy data as requested by the FDA....
Iluvien, a promising sustained drug delivery system for the treatment of diabetic macular edema, fails to pass FDA scrutiny...
Iluvien is a type of drug delivery system that may be FDA approved for treating diabetic retinopathy. Instead of laser treatment, the eye will be injected....
Iluvien, an injectable drug delivery system, gets one step closer to be the first drug FDA approved for the treatment of diabetic macular edema....
Ophthalmic drug delivery is changing with sustained release technology. Icon Biosciences, Inc., announces their intent to test a new anti-inflammatory extended release eye product. ...
Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system....